GSK Applies to EU Regulator for Expanded Use of RSV Vaccine

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults below the age of 50 who are at risk of the disease,...Reuters Health Information